NCT03070197View on ClinicalTrials.gov

Genomic Basis of Neurodevelopmental and Brain Outcomes in Congenital Heart Disease (CHD Brain and Genes)

CompletedOBSERVATIONAL
Enrollment

196

Participants

Timeline

Start Date

September 18, 2017

Primary Completion Date

June 29, 2020

Study Completion Date

June 29, 2020

Conditions
Heart Disease Congenital
Interventions
OTHER

Exposure of interest: Brain MRI

Brain MRI will be conducted in all participants

OTHER

Exposure of interest: neurodevelopmental assessments

neurodevelopmental testing will be conducted in all participants.

Trial Locations (8)

10029

Icahn School of Medicine at Mt. Sinai, New York

14642

University of Rochester, Rochester

19104

Children's Hospital Philadelphia, Philadelphia

84113

University of Utah, Salt Lake City

90027

Children's Hospital Los Angeles, Los Angeles

94158

University of California, San Francisco, San Francisco

06520

Yale University, New Haven

02115

Children's Hospital Boston, Boston

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT03070197 - Genomic Basis of Neurodevelopmental and Brain Outcomes in Congenital Heart Disease (CHD Brain and Genes) | Biotech Hunter | Biotech Hunter